Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy.

[1]  C. Reutelingsperger,et al.  Annexin A1 drives macrophage skewing to accelerate muscle regeneration through AMPK activation , 2020, The Journal of clinical investigation.

[2]  Juan Cheng,et al.  A Proresolving Peptide Nanotherapy for Site‐Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota , 2019, Advanced science.

[3]  C. Thiemermann,et al.  Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes , 2019, Front. Immunol..

[4]  M. Cooper,et al.  Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease. , 2018, Journal of the American Society of Nephrology : JASN.

[5]  F. Gavins,et al.  Therapeutic Potential of Annexin A1 in Ischemia Reperfusion Injury , 2018, International journal of molecular sciences.

[6]  Choon-Sik Park,et al.  Annexin A1 in plasma from patients with bronchial asthma: its association with lung function , 2018, BMC Pulmonary Medicine.

[7]  N. Fountoulakis,et al.  Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes , 2017, Diabetologia.

[8]  Matthias Kretzler,et al.  A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome. , 2017, Kidney international.

[9]  Mark E. Davis,et al.  Store-Operated Ca2+ Channels in Mesangial Cells Inhibit Matrix Protein Expression. , 2015, Journal of the American Society of Nephrology : JASN.

[10]  Y. Hung,et al.  Urine Annexin A1 as an Index for Glomerular Injury in Patients , 2014, Disease markers.

[11]  W. Wurst,et al.  Highly Efficient Targeted Mutagenesis in Mice Using TALENs , 2013, Genetics.

[12]  A. Nagy,et al.  Simple piggyBac transposon-based mammalian cell expression system for inducible protein production , 2013, Proceedings of the National Academy of Sciences.

[13]  J. Navarro-González,et al.  Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy , 2011, Nature Reviews Nephrology.

[14]  Jai Radhakrishnan,et al.  Pathologic classification of diabetic nephropathy. , 2010, Journal of the American Society of Nephrology : JASN.

[15]  B. Rigas,et al.  Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. , 2010, Cancer research.

[16]  C. Alpers,et al.  Mouse models of diabetic nephropathy. , 2005, Journal of the American Society of Nephrology : JASN.

[17]  M. Perretti,et al.  Exploiting the Annexin A1 pathway for the development of novel anti‐inflammatory therapeutics , 2009, British journal of pharmacology.

[18]  K. Sharma,et al.  Transcription factors in the pathogenesis of diabetic nephropathy , 2009, Expert Reviews in Molecular Medicine.

[19]  G. Wolf,et al.  Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. , 2008, Current diabetes reviews.

[20]  C. Serhan,et al.  Anti-inflammatory and proresolving lipid mediators. , 2008, Annual review of pathology.

[21]  B. Croker,et al.  Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy. , 2007, Journal of the American Society of Nephrology : JASN.

[22]  Felix Eichinger,et al.  Modular Activation of Nuclear Factor-κB Transcriptional Programs in Human Diabetic Nephropathy , 2006, Diabetes.

[23]  Nader Rifai,et al.  Inflammatory markers and risk of developing type 2 diabetes in women. , 2004, Diabetes.

[24]  S. Feo,et al.  Anti-inflammatory effects of annexin-1: stimulation of IL-10 release and inhibition of nitric oxide synthesis. , 2003, International immunopharmacology.

[25]  J. Manson,et al.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.

[26]  M. Cooper,et al.  A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR). , 1998, Kidney international.

[27]  R. Hannon,et al.  Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration , 1996, Nature Medicine.

[28]  G. J. Blackwell,et al.  Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation , 1979, Nature.

[29]  A. Damazo,et al.  Annexin 1 localisation in tissue eosinophils as detected by electron microscopy , 2013 .

[30]  Kumar Sharma,et al.  Mouse models of diabetic nephropathy. , 2005, Journal of the American Society of Nephrology : JASN.